Board of Trustees of Dana-Farber Cancer Institute, Inc.

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

whitePaper | July 1, 2022

Too often health is something we try not to think about. We avoid talking about it. We put it off for another day, a better time. Then, something unexpected happens: an illness, an unfortunate incident, or even, as we’ve seen these last two and a half years, a pandemic.

whitePaper | April 7, 2022

The global healthcare industry is facing a seemingly insurmountable number of challenges – from aging populations and staff shortages to rising costs

whitePaper | November 15, 2022

The COVID-19 pandemic has exposed the vulnerabilities of global and national health systems. Already-struggling healthcare systems have shifted their resources to the pandemic response

whitePaper | March 11, 2023

As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities.

whitePaper | March 31, 2022

This is the fifth annual edition of FH® Healthcare Indicators and FH® Medical Price Index, two measures developed by FAIR Health to provide clarity in a rapidly changing healthcare environment